IRIS (Intelligent Retinal Imaging Systems) and Biomedix Sign Strategic Partnership Agreement

Expands Biomedix Population Health Management Solution Today IRIS and Biomedix announced the signing of a strategic partnership agreement that expands the Biomedix Xchange Population Health Management Solution to include the testing, diagnosis and care planning for diabetic retinopathy examinations. “For value-based care organizations, the early identification of diabetic retinopathy through Read more…

New Case Study Available: PAD Risk Identification & Stratification In An Institutional Environment

Biomedix had the opportunity to support a PAD screening initiative at a large Skilled Nursing Facility (SNF). The SNF consisted of a variety of residents, including long-term care, short-term rehabilitation and recovery, and a dementia unit. This screening program was coordinated with MIMIT, making a nationally recognized vascular specialist group Read more…

Social Deprivation

Social Deprivation Increases Risk of Chronic Diseases Such as PAD For Diabetics

A recent study published in Diabetes Care highlighted the relationship between social deprivation and the incidence of diabetes-related foot disease, including lower-extremity amputation, peripheral artery disease, and peripheral neuropathy. This population-based retrospective cohort used data from 2005 through 2019, analyzing the presence of disease based on a quintile analysis through Read more…

Drug Test